AL
Healthcare & Life Sciences
AlloVir
United Statesallovir.com
AlloVir is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
series-b
series-b
Stage
1
Investors
About AlloVir
Based in the United States, AlloVir is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
AlloVir develops off-the-shelf allogeneic virus-specific T cell therapies aimed at treating viral infections in immunocompromised patients, such as those undergoing stem cell or organ transplants.
Explore AlloVir's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.